NeoGenomics Inc. Common Stock vs Telus Corporation Ordinary Shares — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B). The key difference: Telus Corporation Ordinary Shares is far larger — about 5.9× NeoGenomics Inc. Common Stock's market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Telus Corporation Ordinary Shares for 0 Days on average.
| NEO | TU | |
|---|---|---|
Market Cap | $2.14B | $12.52B |
Volume | 2,228,400 | 6,655,034 |
Sector | Health | Media |
52-Week High | $19.91 | $15.33 |
52-Week Low | $7.19 | $7.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $33.57B |
Dividend Yield | — | 6.59% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.
Read more on TU →